ZFHX3 methylation in peripheral blood monocytes as a potential biomarker for pancreatic cancer detection
Pancreatology · 2024
DOI: 10.1016/j.pan.2024.05.529 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pancreatology, 2024. Verfasst von Yongzheng Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pancreatic Surgery, Department of General Surgery, Qilu Hospital, Shandong University, Jinan, 250012, Shandong, China; Department of Gene…. Hauptthemen laut MEDLINE: DNA Methylation, Pancreatic Neoplasms, Biomarkers, Tumor, Monocytes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is the digestive malignancy with poor prognosis, and there is still a lack of effective diagnostic biomarkers. OBJECTIVE: We aimed to explore the diagnostic efficiency of DNA methylation in peripheral blood monocytes (PBMCs) in PDAC. METHODS: 850K BeadChips were used to detect genome-wide methylation of PBMCs. For the selected sites, MethylTarget assays was used for further verification. The support vector machine was used to establish the combined panel. RESULTS: A total of 167 PDAC patients and 113 healthy controls were included in this study and were divided into three sets. In the discovery set, we found 4625 differentially methylated positions (DMPs) between cancer group and healthy controls. ZFHX3 (0.16 ± 0.04 vs. 0.18 ± 0.04, P = 0.001), cg01904886 (0.84 ± 0.05 vs. 0.81 ± 0.04, P = 0.02) and NUMBL (0.96 ± 0.005 vs. 0.957 ± 0.005, P = 0.04) were found to be significantly different in training set. The locus with more significant differences, namely ZFHX3, was used for further validation and to establish a combined diagnostic panel with CA19-9. In the validation set, the ROC curve indicated that the AUC value of ZFHX3 was 0.75. The AUC value of the combined model (AUC = 0.92) was higher than that of CA19-9 alone (AUC = 0.88). In patients with normal CA19-9 levels, the ZFHX3 methylation biomarker still maintained good diagnostic efficacy (AUC = 0.71). CONCLUSION: Our study preliminarily suggests that ZFHX3 methylation combined with CA19-9 can improve the detection rate of PDAC. Especially in patients with normal CA19-9, ZFHX3 methylation can maintain stable diagnostic efficacy. The diagnostic value of ZFHX3 methylation still needs to be prospectively validated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pancreatic Surgery, Department of General Surgery, Qilu Hospital, Shandong University, Jinan, 250012, Shandong, China; Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of…
- Division of Pancreatic Surgery, Department of General Surgery, Qilu Hospital, Shandong University, Jinan, 250012, Shandong, China.
- Department of Clinical Laboratory, The Second Hospital of Shandong University, Jinan, Shandong, China.
- Division of Pancreatic Surgery, Department of General Surgery, Qilu Hospital, Shandong University, Jinan, 250012, Shandong, China. Electronic address: zhanhanxiang@hotmail.com.
Zitieren
APA
Li, Y., Fan, Z., Meng, Y., Yang, J., Li, P., Liu, S., Pang, C., Du, L., Wang, Y., & Zhan, H. (2024). ZFHX3 methylation in peripheral blood monocytes as a potential biomarker for pancreatic cancer detection. Pancreatology. https://doi.org/10.1016/j.pan.2024.05.529
Vancouver
Li Y, Fan Z, Meng Y, Yang J, Li P, Liu S, et al. ZFHX3 methylation in peripheral blood monocytes as a potential biomarker for pancreatic cancer detection. Pancreatology. 2024. doi:10.1016/j.pan.2024.05.529
BibTeX
@article{Li2024,
author = {Li, Yongzheng and Fan, Zhiyao and Meng, Yufan and Yang, Jian and Li, Peilong and Liu, Shujie and Pang, Chaoyu and Du, Lutao and Wang, Yunshan and Zhan, Hanxiang},
title = {ZFHX3 methylation in peripheral blood monocytes as a potential biomarker for pancreatic cancer detection},
journal = {Pancreatology},
year = {2024},
doi = {10.1016/j.pan.2024.05.529}
}
EUVIMED